1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Arpida AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia iclaprim, vancomycin - Hospital-Acquired Pneumonia, Ventilator-Associated Pneumonia | Phase 2 | Terminated | Arpida AG | 135 | 2007-11-01 | 2009-02-13 |
Healthcare-Associated Pneumonia (1) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1)
Vancomycin (1) · iclaprim (1)
David Willms, MD (1)